Caring for the Ages
October 30, 2020
Showing 7081 - 7090 of 7399 results
JAMDA
September 24, 2020
Use of Alcohol in Long Term Care Settings: A Comparative Analysis of Personal Choice, Public Health Advice and the Law
Alcohol is one of the most widely available psychoactive substances globally. Many accept the risks associated with alcohol consumption for reasons such as social engagement and feelings of pleasure. Alcohol consumption in a nursing home (NH) setting highlights the moral and logistical challenges of balanc...
JAMDA
February 26, 2020
Use of an Electronic Deprescribing Tool at the Long-Term Care Quarterly Medication Review
JAMDA
August 23, 2017
Use of an Exercise Technology in Post-Acute Care of a Skilled Nursing Facility: A Feasibility Study
Use of exercise technologies has benefits for community-dwelling older adults in terms of improved gait and balance. But research on the feasibility of use of exercise technologies in various geriatric health care settings is lacking. Hence, the current study examined the feasibility of implementing an exe...
JAMDA
March 22, 2019
Use of Anticholinergic Drugs According to Various Criteria and Their Association With Psychological Well-Being and Mortality in Long-Term Care Facilities
To compare 3 internationally established criteria for drugs with anticholinergic properties (DAPs) and their associated factors in long-term care facilities, and to investigate the association between use of DAPs and psychological well-being (PWB) or mortality.
JAMDA
December 26, 2017
Use of Anticholinergic Drugs and its Relationship With Psychological Well-Being and Mortality in Long-Term Care Facilities in Helsinki
To assess the burden of drugs with anticholinergic properties (DAPs) and associated factors in long-term care facilities and to explore how psychological well-being and mortality are associated with the use of DAPs.
JAMDA
September 24, 2014
Use of Antipsychotic Drugs Among Residents With Dementia in European Long-Term Care Facilities: Results From the SHELTER Study
Behavioral and psychological symptoms of dementia (BPSD) are common reasons for use of antipsychotic drugs among older individuals with dementia. These drugs are not approved for such use and both the Food and Drug Administration and European Medicines Agency have issued warnings to limit such use.
Caring for the Ages
March 31, 2017
Use of Antipsychotics Does Not Reduce Delirium Symptom Scores
JAMDA
August 5, 2023
Use of Diabetes Medications before and after a Heart Failure–Related Hospitalization among Nursing Home Residents
Sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) offer cardiovascular benefits, whereas thiazolidinediones (TZDs) and sulfonylureas (SUs) increase cardiovascular risk. The objective of this study was to describe the use of SGLT-2is, GLP-1RAs, TZD...
JAMDA
September 1, 2016